TearCare System to Treat Dry Eye Disease

NACompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

March 3, 2019

Primary Completion Date

February 17, 2020

Study Completion Date

December 18, 2020

Conditions
Dry EyeMeibomian Gland Dysfunction
Interventions
DEVICE

TearCare

The TearCare SmartLids will be applied to the external surface of each eyelid. The TearCare System will be turned on and heat will be delivered to the eyelids for 15 minutes. Immediately following the thermal portion of the procedure, the SmartLids will be removed and the doctor will manually express the meibomian glands.

DEVICE

LipiFlow

The LipiFlow activators will be placed between the inner eyelid and the corneal surface of each eye. The LipiFlow System will be turned on and heat and pressure will be delivered to each eyelid for 12 minutes.

Trial Locations (10)

33143

Loh Ophthalmology Associates, Miami

40517

Kentucky Eye Institute, Lexington

41017

Cincinnati Eye Institute, Edgewood

57108

Vance Thompson Vision, Sioux Falls

60046

Jackson Eye, Lake Villa

63131

Ophthalmology Associates, St Louis

78229

Parkhurst NuVision, San Antonio

85260

Schwartz Laser Eye Center, Scottsdale

92653

Harvard Eye Associates, Laguna Hills

92663

Eye Research Foundation, Newport Beach

All Listed Sponsors
lead

Sight Sciences, Inc.

INDUSTRY

NCT03857919 - TearCare System to Treat Dry Eye Disease | Biotech Hunter | Biotech Hunter